King of Prussia, Pennsylvania-based Common Well being Companies, Inc. (UHS) owns and operates acute care hospitals, and outpatient and behavioral well being care amenities. Valued at a market cap of $12 billion, the corporate’s vary of providers embrace normal and specialty surgical procedure, inner drugs, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric providers, pharmacy providers, and behavioral well being providers. It’s anticipated to announce its fiscal Q2 earnings for 2025 on Wednesday, Jul. 23.
Previous to this occasion, analysts undertaking this healthcare firm to report a revenue of $4.87 per share, up 13% from $4.31 per share within the year-ago quarter. The corporate has exceeded Wall Road’s bottom-line estimates in three of the final 4 quarters, whereas lacking on one other event. Its earnings of $4.84 per share within the earlier quarter outpaced the consensus estimates by 11%.
For the complete yr, analysts anticipate UHS to report EPS of $19.43, up 17% from $16.61 in fiscal 2024. Moreover, its EPS is anticipated to develop 8.9% year-over-year to $21.16 in fiscal 2026.
UHS has declined marginally over the previous 52 weeks, lagging behind the S&P 500 Index’s ($SPX) 13% return over the identical timeframe. Nevertheless, it has outpaced the Well being Care Choose Sector SPDR Fund’s (XLV) 6.3% downtick over the identical time interval.
On Apr. 28, UHS launched its Q1 outcomes, and its shares closed down marginally within the following buying and selling session. The corporate’s general income improved 6.7% year-over-year to $4.1 billion however fell in need of the consensus estimates by practically 1%. In the meantime, on the earnings entrance, resulting from favorable pricing and margin enchancment, the corporate’s adjusted EPS surged 30.8% year-over-year to $4.84 and surpassed the analyst estimates by 11%.
Wall Road analysts are reasonably optimistic about UHS’ inventory, with a “Average Purchase” score general. Amongst 19 analysts overlaying the inventory, eight suggest “Sturdy Purchase,” and 11 advise “Maintain.” The imply worth goal for UHS is $226.19, which signifies a 22.6% potential upside from the present ranges.
On the date of publication, Neharika Jain didn’t have (both straight or not directly) positions in any of the securities talked about on this article. All data and knowledge on this article is solely for informational functions. This text was initially revealed on Barchart.com